UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

1-2 非小細胞肺癌における検体採取方法別EGFR遺伝子変異検出に関する検討(<特集>第29回日本呼吸器内視鏡学会総会)

気管支学, 2006/12/25, Vol.28(8), pp.597-600

2006

Volltextzugriff (PDF)

1,25-dihydroxyvitamin D3 signaling-induced decreases in IRX4 inhibits NANOG-mediated cancer stem-like properties and gefitinib resistance in NSCLC cells

Cell death & disease, 2020-08, Vol.11 (8), p.670, Article 670

2020

Volltextzugriff (PDF)

1．薬剤性肺炎と日本人

日本内科学会雑誌, 2007, Vol.96(6), pp.1077-1082

2007

Volltextzugriff (PDF)

109th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 1. Recent treatments and progress in malignant tumors--chemotherapy and molecular targeting agents. Antibody therapy; 3) Non-small cell lung cancer

Nihon Naika Gakkai zasshi, 2012-09, Vol.101 (9), p.2520-2525

Kobayashi, Kunihiko

2012

Volltextzugriff (PDF)

17β-estradiol-induced growth of triple-negative breast cancer cells is prevented by the reduction of GPER expression after treatment with gefitinib

Oncology reports, 2017-02, Vol.37 (2), p.1212-1218

2017

Volltextzugriff (PDF)

1880-P: Distinct Roles of UVRAG and EGFR Signaling in Skeletal Muscle Homeostasis

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

2）内科医からみた先制医療：肺癌

日本内科学会雑誌, 2015/09/10, Vol.104(9), pp.1808-1811

萩原, 弘一

2015

Volltextzugriff (PDF)

20 years since the approval of first EGFR-TKI, gefitinib: Insight and foresight

Biochimica et biophysica acta. Reviews on cancer, 2023-11, Vol.1878 (6), p.188967-188967, Article 188967

2023

Volltextzugriff (PDF)

IL-22 Confers EGFR-TKI Resistance in NSCLC via the AKT and ERK Signaling Pathways

Frontiers in oncology, 2019-11, Vol.9, p.1167-1167

2019

Volltextzugriff (PDF)

244-MPT overcomes gefitinib resistance in non-small cell lung cancer cells

Oncotarget, 2015-12, Vol.6 (42), p.44274-44288

2015

Volltextzugriff (PDF)

3,6,2′,4′,5′-Pentahydroxyflavone, an Orally Bioavailable Multiple Protein Kinase Inhibitor, Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer

The Journal of biological chemistry, 2014-10, Vol.289 (41), p.28192-28201

2014

Volltextzugriff (PDF)

3-Deoxysappanchalcone Inhibits Cell Growth of Gefitinib-Resistant Lung Cancer Cells by Simultaneous Targeting of EGFR and MET Kinases

Biomolecules & therapeutics, 2023, Vol.31 (4), p.446-455

2023

Volltextzugriff (PDF)

3-Deoxysappanchalcone Inhibits Cell Growth of Gefitinib-Resistant Lung Cancer Cells by Simultaneous Targeting of EGFR and MET Kinases

Biomolecules & therapeutics, 2023-07, Vol.31 (4), p.446-455

2023

Volltextzugriff (PDF)

374 Therapeutic Class Labeling of EGFR Companion Diagnostics (CDxs)

Journal of clinical and translational science, 2022-04, Vol.6 (s1), p.70-70

2022

Volltextzugriff (PDF)

3D printing injectable microbeads using a composite liposomal ink for local treatment of peritoneal diseases

Drug delivery and translational research, 2024-06, Vol.14 (6), p.1567-1581

2024

Volltextzugriff (PDF)

4,5-Diaryl 3( 2H )Furanones: Anti-Inflammatory Activity and Influence on Cancer Growth

Molecules (Basel, Switzerland), 2019-05, Vol.24 (9), p.1751

2019

Volltextzugriff (PDF)

4 - Breast cancer resistance protein (BCRP)/ABCG2

Transporters in drug discovery and development, 2013, p.295-326

Yurong Lai

2013

Volltextzugriff (PDF)

5-aminolaevulinic acid/photo-dynamic therapy and gefitinib in non-small cell lung cancer cell lines: a potential strategy to improve gefitinib therapeutic efficacy

Cell proliferation, 2013-08, Vol.46 (4), p.382-395

2013

Volltextzugriff (PDF)

5-Aza-CdR can reverse gefitinib resistance caused by DAPK gene promoter methylation in lung adenocarcinoma cells

International journal of clinical and experimental pathology, 2015-01, Vol.8 (10), p.12961-12966

2015

Volltextzugriff (PDF)

6-Shogaol Overcomes Gefitinib Resistance via ER Stress in Ovarian Cancer Cells

International journal of molecular sciences, 2023-01, Vol.24 (3), p.2639

2023

Volltextzugriff (PDF)

8.02 - Pyrimidines and their Benzo Derivatives

Comprehensive Heterocyclic Chemistry III, 15-Volume Set, 2008, p.117-272

Rewcastle, G.W.

2008

Volltextzugriff (PDF)

IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer

Oncotarget, 2015-04, Vol.6 (12), p.10415-10431

2015

Volltextzugriff (PDF)

IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib

Oncotarget, 2016-07, Vol.7 (27), p.42031-42044

2016

Volltextzugriff (PDF)

ABCB1 Transporter Allelic Variants and Dermatologic Adverse Reactions Related to Gefitinib Therapy in Lung Cancer Patients: A Pilot Study

Drug safety, 2022-10, Vol.45 (10), p.1169-1169

2022

Volltextzugriff (PDF)

ABCC10 Plays a Significant Role in the Transport of Gefitinib and Contributes to Acquired Resistance to Gefitinib in NSCLC

Frontiers in pharmacology, 2018-11, Vol.9, p.1312-1312

2018

Volltextzugriff (PDF)

1 – 25 von 5.066

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.497)
Mit Volltextzugriff
(4.514)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

9 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Gefitinib
(4.652)
Science & Technology
(4.109)
Life Sciences & Biomedicine
(3.786)
Humans
(3.208)
Oncology
(2.336)
Lung Cancer
(1.737)
Lung Neoplasms - Drug Therapy
(1.690)
Mutation
(1.412)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(1.405)
Female
(1.356)
Male
(1.134)
Quinazolines - Therapeutic Use
(1.022)
Tumors
(996)
Antineoplastic Agents - Therapeutic Use
(993)
Lung Neoplasms - Genetics
(982)
Epidermal Growth Factor
(974)
Cell Line, Tumor
(962)
Middle Aged
(962)
Kinases
(948)
Aged
(911)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(3.355)
EZB Electronic Journals Library
(2.941)
Ingenta
(2.593)
IngentaConnect Journals
(1.725)
Journals@Ovid Ovid Full Text
(1.698)
Elsevier ScienceDirect Journals Complete
(830)
Springer journals
(652)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(597)
Publisher website
(552)
Wiley Online Library
(533)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(367)
Taylor & Francis Journals Auto-Holdings Collection
(328)
Nature Journals Online
(314)
Wiley Online Library
(275)
Nexis Uni
(255)
Taylor & Francis
(237)
Taylor & Francis E-Journals
(167)
SAGE Journals Online
(86)
Oxford journals
(61)
Oxford Journals 2020 Medicine
(50)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Lung Cancer
(198)
Plos One
(135)
Journal Of Thoracic Oncology
(107)
Anticancer Research
(77)
British Journal Of Cancer
(72)
Clinical Cancer Research
(70)
Annals Of Oncology
(66)
Scientific Reports
(66)
Clinical Lung Cancer
(65)
Cancer Chemotherapy And Pharmacology
(64)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(28)

Menü

Weitere Dienste

Einstellungen

1-2 非小細胞肺癌における検体採取方法別EGFR遺伝子変異検出に関する検討(<特集>第29回日本呼吸器内視鏡学会総会)

1,25-dihydroxyvitamin D3 signaling-induced decreases in IRX4 inhibits NANOG-mediated cancer stem-like properties and gefitinib resistance in NSCLC cells

1．薬剤性肺炎と日本人

109th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 1. Recent treatments and progress in malignant tumors--chemotherapy and molecular targeting agents. Antibody therapy; 3) Non-small cell lung cancer

17β-estradiol-induced growth of triple-negative breast cancer cells is prevented by the reduction of GPER expression after treatment with gefitinib

1880-P: Distinct Roles of UVRAG and EGFR Signaling in Skeletal Muscle Homeostasis

2）内科医からみた先制医療：肺癌

20 years since the approval of first EGFR-TKI, gefitinib: Insight and foresight

IL-22 Confers EGFR-TKI Resistance in NSCLC via the AKT and ERK Signaling Pathways

244-MPT overcomes gefitinib resistance in non-small cell lung cancer cells

3,6,2′,4′,5′-Pentahydroxyflavone, an Orally Bioavailable Multiple Protein Kinase Inhibitor, Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer

3-Deoxysappanchalcone Inhibits Cell Growth of Gefitinib-Resistant Lung Cancer Cells by Simultaneous Targeting of EGFR and MET Kinases

3-Deoxysappanchalcone Inhibits Cell Growth of Gefitinib-Resistant Lung Cancer Cells by Simultaneous Targeting of EGFR and MET Kinases

374 Therapeutic Class Labeling of EGFR Companion Diagnostics (CDxs)

3D printing injectable microbeads using a composite liposomal ink for local treatment of peritoneal diseases

4,5-Diaryl 3( 2H )Furanones: Anti-Inflammatory Activity and Influence on Cancer Growth

4 - Breast cancer resistance protein (BCRP)/ABCG2

5-aminolaevulinic acid/photo-dynamic therapy and gefitinib in non-small cell lung cancer cell lines: a potential strategy to improve gefitinib therapeutic efficacy

5-Aza-CdR can reverse gefitinib resistance caused by DAPK gene promoter methylation in lung adenocarcinoma cells

6-Shogaol Overcomes Gefitinib Resistance via ER Stress in Ovarian Cancer Cells

8.02 - Pyrimidines and their Benzo Derivatives

IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer

IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib

ABCB1 Transporter Allelic Variants and Dermatologic Adverse Reactions Related to Gefitinib Therapy in Lung Cancer Patients: A Pilot Study

ABCC10 Plays a Significant Role in the Transport of Gefitinib and Contributes to Acquired Resistance to Gefitinib in NSCLC

Suchergebnisse filtern